Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 27 March 2012
Vol. 5, Issue 217, p. ra25
Computing TOR Regulation
Without effective genetic or specific pharmacological tools, it can be challenging to dissect regulatory mechanisms in complex, interconnected pathways. Dalle Pezze et al. combined computational modeling with biochemical analysis to test specific regulatory mechanisms of the mammalian target of rapamycin (mTOR) pathway, in particular the regulation of mTOR complex mTORC2, which has important functions in controlling cell growth. After identifying key network components that could be experimentally monitored to explicitly test specific network structures, they compared the experimental data to the modeled networks to rule out previously suggested regulatory mechanisms and postulated the existence of a previously unknown pathway. Their results led to the proposal of a distinct phosphoinositide 3-kinase–dependent pathway from the insulin receptor to mTORC2 that is independent of various components that participate in the activation of mTORC1 and thus should open new areas of research into mTOR signaling and could provide direction for developing selective regulators of mTORC1 and mTORC2 signaling.
Citation: P. Dalle Pezze, A. G. Sonntag, A. Thien, M. T. Prentzell, M. Gödel, S. Fischer, E. Neumann-Haefelin, T. B. Huber, R. Baumeister, D. P. Shanley, K. Thedieck, A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation. Sci. Signal.5, ra25 (2012).